BDS
AZN icon

Banco de Sabadell’s AstraZeneca AZN Stock Holding History

Banco de Sabadell’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,387
Closed -$619K – 63
2025
Q4 		$619K Buy
3,387
+620
+22% +$109K 0.4% 56
2025
Q3 		$420K Sell
2,767
-242
-8% -$36.6K 0.28% 58
2025
Q2 		$418K Sell
3,009
-1,436
-32% -$201K 0.29% 58
2025
Q1 		$652K Buy
4,445
+48
+1% +$6.95K 0.5% 55
2024
Q4 		$575K Buy
4,397
+605
+16% +$84.7K 0.45% 54
2024
Q3 		$593K Buy
3,792
+280
+8% +$45.2K 0.44% 56
2024
Q2 		$545K Buy
3,512
+109
+3% +$16.4K 0.4% 57
2024
Q1 		$458K Sell
3,403
-13
-0.4% -$1.72K 0.34% 60
2023
Q4 		$455K Sell
3,416
-9
-0.3% -$1.17K 0.35% 61
2023
Q3 		$460K Buy
3,425
+712
+26% +$97.2K 0.4% 60
2023
Q2 		$386K Sell
2,713
-10
-0.4% -$1.47K 0.31% 59
2023
Q1 		$381K Sell
2,723
-114
-4% -$15.3K 0.32% 59
2022
Q4 		$384K Buy
2,837
+56
+2% +$7.02K 0.32% 56
2022
Q3 		$304K Sell
2,781
-359
-11% -$45.5K 0.25% 61
2022
Q2 		$412K Sell
3,140
-84
-3% -$11K 0.35% 55
2022
Q1 		$425K Buy
3,224
+229
+8% +$27.5K 0.25% 65
2021
Q4 		$351K Buy
2,995
+276
+10% +$32.5K 0.2% 70
2021
Q3 		$328K Sell
2,719
-158
-5% -$18.4K 0.22% 75
2021
Q2 		$345K Buy
2,877
+190
+7% +$20.8K 0.23% 77
2021
Q1 		$266K Sell
2,687
-56
-2% -$5.63K 0.03% 201
2020
Q4 		$274K Buy
2,743
+183
+7% +$19.4K 0.03% 217
2020
Q3 		$279K Buy
2,560
+81
+3% +$9.01K 0.03% 251
2020
Q2 		$263K Sell
2,479
-301
-11% -$31.1K 0.03% 204
2020
Q1 		$250K Buy
2,780
+21
+0.8% +$1.98K 0.04% 219
2019
Q4 		$276K Sell
2,759
-93
-3% -$8.76K 0.04% 243
2019
Q3 		$256K Sell
2,852
-64
-2% -$5.55K 0.04% 248
2019
Q2 		$242K Buy
+2,916
New +$229K 0.03% 264

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Banco de Sabadell's AZN Position: Q1 2026 in Review

Banco de Sabadell sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 3,387 shares — an estimated $619K sold.

Banco de Sabadell first reported a position in AZN in Q2 2019 and held it in 27 quarters. The position peaked at $652K in Q1 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Banco de Sabadell reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Banco de Sabadell sold 3,387 AstraZeneca shares in Q1 2026, an estimated $619K.
  • Banco de Sabadell first reported a position in AstraZeneca in Q2 2019 and held it in 27 quarters.
  • Banco de Sabadell's AstraZeneca position peaked at $652K in Q1 2025.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Banco de Sabadell's 13F filing for Q1 2026, filed 8 May 2026.